Patients with pre-existing high blood pressure are more likely to be susceptible to heart damage caused by anthracyclines, the most widely used chemotherapy drugs for cancer treatment for more than 30 ...
Stockhead on MSN
Scott Power: ASX healthcare stocks lift as sentiment improves
Morgans Scott Power positive of renewed momentum in the healthcare sector, which has risen 0.7% in the week ending January 16 ...
Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.
Zacks Investment Research on MSN
Bayer stock jumps on Nubeqa outlook, presents pharma strategy
Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish ...
The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...
Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback